SKYE News & Analysis

Skye Bioscience (SKYE) Director Sells $140,313 in Stock

Andrew Schwab, a director at Skye Bioscience (SKYE), sold stock worth $140,313. This transaction reflects actions taken by company insiders that may influence investor sentiment. Insider selling can often signal a lack of confidence in a company's future prospects or may simply be a personal financial decision. Monitoring such transactions is important for ordinary investors as they can provide insights into the potential future performance of a stock.